These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25651487)

  • 1. Difficulty Achieving Vitamin D Sufficiency With High-Dose Oral Repletion Therapy in Infants With Cholestasis.
    Jensen M; Abu-El-Haija M; Bishop W; Rahhal RM
    J Pediatr Gastroenterol Nutr; 2015 Aug; 61(2):187-9. PubMed ID: 25651487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis.
    Boyle MP; Noschese ML; Watts SL; Davis ME; Stenner SE; Lechtzin N
    Am J Respir Crit Care Med; 2005 Jul; 172(2):212-7. PubMed ID: 15860755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription ergocalciferol dosing for vitamin D repletion: a retrospective evaluation.
    Vande Griend JP; McQueen RB; Linnebur SA; Vondracek SF
    Pharmacotherapy; 2012 Feb; 32(2):135-41. PubMed ID: 22392422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients.
    Simoneau T; Sawicki GS; Milliren CE; Feldman HA; Gordon CM
    J Cyst Fibros; 2016 Mar; 15(2):234-41. PubMed ID: 26211605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of vitamin D repletion regimens to correct vitamin D status in adults.
    Pepper KJ; Judd SE; Nanes MS; Tangpricha V
    Endocr Pract; 2009 Mar; 15(2):95-103. PubMed ID: 19342361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis.
    Boas SR; Hageman JR; Ho LT; Liveris M
    J Cyst Fibros; 2009 Jul; 8(4):270-2. PubMed ID: 19447079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of a single oral megadose of vitamin D provided as either ergocalciferol (D₂) or cholecalciferol (D₃) in alcoholic liver cirrhosis.
    Malham M; Peter Jørgensen S; Lauridsen AL; Ott P; Glerup H; Dahlerup JF
    Eur J Gastroenterol Hepatol; 2012 Feb; 24(2):172-8. PubMed ID: 22027703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D; Byham-Gray L; Lewis E; McCaffrey S
    J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Stoss Therapy Be Used in Children with Vitamin D Deficiency or Insufficiency without Rickets?
    Koçyiğit C; Çatlı G; İnce G; Özkan EB; Dündar BN
    J Clin Res Pediatr Endocrinol; 2017 Jun; 9(2):150-155. PubMed ID: 28077342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D in newborns. A randomised controlled trial comparing daily and single oral bolus vitamin D in infants.
    Huynh J; Lu T; Liew D; Doery JC; Tudball R; Jona M; Bhamjee R; Rodda CP
    J Paediatr Child Health; 2017 Feb; 53(2):163-169. PubMed ID: 27670154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 300,000 and 600,000 IU Oral Vitamin-D Bolus for Vitamin-D Deficiency in Young Children.
    Harnot J; Verma S; Singhi S; Sankhyan N; Sachdeva N; Bharti B
    Indian J Pediatr; 2017 Feb; 84(2):111-116. PubMed ID: 27683282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral absorbable fat-soluble vitamin formulation in pediatric patients with cholestasis.
    Shen YM; Wu JF; Hsu HY; Ni YH; Chang MH; Liu YW; Lai HS; Hsu WM; Weng HL; Chen HL
    J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):587-91. PubMed ID: 22595974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of vitamin D deficiency within a large integrated health care delivery system.
    Stratton-Loeffler MJ; Lo JC; Hui RL; Coates A; Minkoff JR; Budayr A
    J Manag Care Pharm; 2012 Sep; 18(7):497-505. PubMed ID: 22971203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response effect of ergocalciferol therapy on serum 25-hydroxyvitamin D concentration during critical illness.
    Dickerson RN; Berry SC; Ziebarth JD; Swanson JM; Maish GO; Minard G; Brown RO
    Nutrition; 2015 Oct; 31(10):1219-23. PubMed ID: 26213135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers.
    Leaf DE; Korets R; Taylor EN; Tang J; Asplin JR; Goldfarb DS; Gupta M; Curhan GC
    Clin J Am Soc Nephrol; 2012 May; 7(5):829-34. PubMed ID: 22422535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single high-dose oral vitamin D3 (stoss) therapy--a solution to vitamin D deficiency in children with cystic fibrosis?
    Shepherd D; Belessis Y; Katz T; Morton J; Field P; Jaffe A
    J Cyst Fibros; 2013 Mar; 12(2):177-82. PubMed ID: 22998937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early response to vitamin D2 in children with calcium deficiency rickets.
    Thacher TD; Fischer PR; Isichei CO; Pettifor JM
    J Pediatr; 2006 Dec; 149(6):840-4. PubMed ID: 17137904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D deficiency and its correction in children with sickle cell anaemia.
    Wykes C; Arasaretnam A; O'Driscoll S; Farnham L; Moniz C; Rees DC
    Ann Hematol; 2014 Dec; 93(12):2051-6. PubMed ID: 24981689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current treatment recommendations for correcting vitamin D deficiency in pediatric patients with cystic fibrosis are inadequate.
    Green D; Carson K; Leonard A; Davis JE; Rosenstein B; Zeitlin P; Mogayzel P
    J Pediatr; 2008 Oct; 153(4):554-9. PubMed ID: 18589445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vitamin D supplementation for chronic kidney disease according to the guideline issued by DOQI].
    Watanabe Y
    Clin Calcium; 2004 May; 14(5):778-85. PubMed ID: 15577042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.